Absci appoints Dr. Joseph Sirosh to board effective Jan 7, 2022

Absci Corp

Dr. Joseph Sirosh appointed as Class III director, term until 2024 annual meeting.
Board size increased to seven directors; Sirosh fills new third Class III seat.
Received initial option grant for 45,180 shares at $7.19, vesting monthly over 3 years.
Also receives annual $40,000 cash retainer under Non-Employee Director Compensation Policy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Joseph Sirosh

Class III Director

ABSI · Absci Corp

Effective: 2022-01-07
Filed: January 10, 2022, 6:59 PM ET

On January 7, 2022, the Board of Directors (the “Board”) of Absci Corporation (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Joseph Sirosh to the Board effective that same date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Joseph Sirosh was appointed as Class III Director at Absci Corp.

Action: appointed
Role: Class III Director

Exact text from the filing

On January 7, 2022, the Board of Directors (the “Board”) of Absci Corporation (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Joseph Sirosh to the Board effective that same date.

View on SEC.gov

Absci Corp filing history →

Source: SEC EDGAR

accession 0001628280-22-000579

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.